Clinical Trial Update: Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes [Phase 2]

View source ↗

Summary

This clinical trial update reports an ongoing Phase 2 study evaluating the efficacy and safety of once-weekly KAI-9531 in adults with obesity who do not have di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• KAI-9531

Snippet

Sponsor: Kailera | Conditions: Obesity | Phase 2 | Status: RECRUITING